Background
Methods
Validation approach
Identification of validation frameworks in literature
Selection of data validity concepts
Defining the selected concepts
Example case
Application
Data
Hospital A | Hospital B | |
---|---|---|
Number of beds | 1100 | 471 |
Annual number of RBC transfusions | 12,653 | 6681 |
Presence of typical transfusion specialisms | Hematology, oncology, thoracic surgery, trauma center | Hematology, oncology, thoracic surgery, trauma center (and heavy emphasis on major vascular / aneurysm surgery and obstetrics) |
Results
Validation Approach
|
Application
| |||
---|---|---|---|---|
Order | Concept | Aim | Outcome | Average of two hospitals |
External
| ||||
1 | Concordance with report | Data are concordant with (annual) report | % agreement between number of products in annual blood bank report and DWH | 98.7% (RBC 99.2%, PLT 97.6%, FFP 98.7%) |
10 | Concordance with literature | Data are concordant with previous findings in literature | Comparison of distribution of blood products by age and gender per product type in the Netherlands | Distributions were quite similar, only platelet use has shifted towards younger patients (Additional file 1: Figure S2.4). |
11 | Concordance with experts | Data are concordant with expert opinions; findings can be explained in a clinical context | Plausibility of changes in Hb after blood transfusion | The experts concluded that the plausibility is acceptable; the 1% unexpected decreases might be explained by other factors. |
12 | Concordance with other databases | Findings are concordant with other databases | Comparison of findings with SCANDAT, a Scandinavian transfusion database | The SCANDAT database has similar external concordance, completeness and linkage rates. |
Internal
| ||||
2 | Linkage data sources within DWH | Entities occurring in multiple data tables can be linked | % transfusions linked to issued products by id of the end product | 99.96% (no link for n = 46 RBC, n = 5 PLT, and n = 1 FFP) |
% products issued linked to transfusion (indicates spilling rate) | 97.65% (RBC 97.95%, PLT 99.25%, FFP 93.35%) | |||
% products that can be linked to donation(s); % products linked to donors | Initially 96.73%, after improving the donation numbers this increased to 99.99%; the link from product to donor was 99.98% | |||
3 | Identity | No duplicates | % duplicated transfusions (donation identification code + product type) | 0.14% (initially this was 1%; it turned out that most duplicates were split products. Due to unavailable product codes in one hospital, the broader product type had to be used) |
% duplicated donations (donation identification code + product code) | 0.005% (RBCs); 0% (FFP and PLT) | |||
% duplicated procedures codes | 0% (all duplicates were removed, because it was expected that double registration would occur) | |||
4 | Completeness | No missing variables or values | % patient ID; date of birth; gender, procedure date; Hb and thrombocyte counts; product code | 100%; 99.99%; 99.99%; 100%; 99.8% and 97.5%; 50% |
% non-missing values for donor ID; date of birth; gender, Hb value, Expiration or Production date | 100%; 99,995%; 100%; 98.8%; 100% | |||
% of transfusions that fall within at least one diagnosis start and end date | 98% (see Additional file 1: Table S2.1) | |||
5 | Uniformity | Measures across time and data sources all have the same units, level of detail and/or coding system | % product codes that occur in the reference list of ISBT product codes | 50% (for one hospital product code was not available) |
% Diagnosis codes that occur in the reference list (of national diagnosis codes and descriptions) | 96.1% | |||
% of Hb measurements from hospitals and blood bank with the same level of precision | >99.6% uses 1 significant decimal in all sources | |||
6 | Time patterns | No unexplained changes over time | Compare number of donations, products and donors of subsequent (calendar) years | The observed decrease (Additional file 1: Figure S2.1) is in line with the known nationally decreasing trend. |
Examine number of transfusions per year per product type | The relatively high decrease for FFP use (Additional file 1: Figure S2.2) can be explained by the introduction of ROTEM, a hemostasis testing method. | |||
Examine linkage percentage of transfusions to products issued per year | In 2010 relatively many unlinked transfusions occurred (see Additional file 1: Figure S2.3). After blood bank data from the previous year 2009 was included, the linkage percentage increased to 99.8% or higher for all years. | |||
7 | Plausibility | Data are free of identifiable errors | % donation date < date of pooling | 100% |
% within limits for number of donations per donor per year (maximum is 3 (females) or 5 (males) for whole blood and 23 for plasma) | FFP 100%; WB 99.8% (0.2% exceeds the limit with in total 6 or 7 donations within a year) | |||
% donor age > 18 and >70 years (minimum and maximum age for donating) | 100% (only 0.0006% was >70 and 0.0004% was <18 and these were mainly autologous donations) | |||
% transfusion with increase (and decrease) in Hb level (Hb values + − 1 day around transfusion; difference > + − 8.8% is considered a clinical change) | 54% increases; 6% decreases; 40% no change. Of those decreasing, 97% had a diagnosis indicating high bleeding risk | |||
% patient age < 121 years | 100% | |||
Maximum number of transfusions per year | Max tr. per year 476 (mainly FFP) for diagnosis TTP. | |||
% correct gender for Gynecology diagnoses | 100% | |||
% patients with transfusions/ surgery after date of death | 0.0% (n = 2 changed mortality status to NA) | |||
% with admission date before discharge date) (zero-length rule) | 100% | |||
% with non-negative difference between expiration and transfusion date | 99.93% | |||
8 | Event attributes | All attributes relevant to an event description are present | % of pooled products that are linked to the correct number of unique donors (in this case 5 or 6 donors contribute to one pooled platelet product) | 100% |
% of patients that are transferred to another hospital according to the ‘discharge destination’ variable | 6% | |||
% transfusions linked to hospitalization (indicates outpatient transfusions) | 99.16% (of which 23.64% day admissions, likely including transfusions given at the outpatient ward) | |||
9 | Consistency hospitals within DWH | No unexplained differences between hospitals | Comparison of (validity) outcomes of the hospitals | The two hospitals have very similar validity outcomes, not requiring further investigation. |
Outcome | SCANDAT 1/2 | DTD example |
---|---|---|
External concordance of database and official statistics on the number of transfusions | >97% | >98.7% for products and 99.96% for transfusions |
% transfusions linked to the corresponding donor | 95% | 99.99% |
% transfusions linked to hospitalization | 88.7% | 99.2% (of which 23.6% day admissions) |
% duplicated donations and transfusions | 4.9% (donations) and 9.1% (transfusions) | 0% (donations) and 0.14% (transfusions) |
% missing or invalid values for identification number or date values | Range between 0.1% to 3.6% | 0%–0.01% |
Time patterns for donations and transfusion counts | In 1 year approximately 160,000 transfusions were missing; it took 2 years for the number of donations and transfusions to stabilize after the start of a new registration system | In 1 year the link of transfusions to products could be made for 2.2%, however this could be improved by adding donation data from the previous year |
% of recipients had records of receiving a blood transfusion in two or more local registers | 8.9% | 6% of patients are transferred to another hospital |